Stocks and Investing Stocks and Investing
Mon, October 21, 2019
Fri, October 18, 2019

Michael King Maintained (SYRS) at Buy with Decreased Target to $160 on, Oct 18th, 2019


Published on 2024-10-26 17:05:26 - WOPRAI, Michael King
  Print publication without navigation


Michael King of JMP Securities, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $180 to $160 on, Oct 18th, 2019.

Michael, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources